Notable Analyst Rating Changes 01/19: (BSX) (HMA) (UBS) Upgraded; (CVA) (SYK) (DHI) Downgraded
UPGRADES
Bernstein upgrades Boston Scientific (NYSE: BSX) from Market Perform to Outperform, its price target raised $6.50 to $7.
Deutsche Bank lifts Health Management (NYSE: HMA) from Hold to Buy, its price target lowered from $9.50 to $8.50. Click Here for more color.
Morgan Stanley raises UBS AG (NYSE: UBS) from Equal Weight to Overweight.
Canaccord Genuity boosts Garmin Ltd. (Nasdaq: GRMN) from Hold to Buy, its price target raised from $37 to $47.50. Click Here for more color.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES
BofA/Merrill Lynch downgrades Covanta (NYSE: CVA) from Buy to Neutral.
Bernstein lowers Stryker (NYSE: SYK) from Outperform to Market Perform, its price target cut from $57 to $56.
UBS reduces D.R. Horton (NYSE: DHI) from Buy to Neutral. Click Here for more color.
Goldman Sachs drops Walgreen (NYSE: WAG) from Buy to Neutral with a price target of $35 (down from $38). Click Here for more color.
For daily real-time Downgrades go to http://www.streetinsider.com/downgrades
NEW COVERAGE
William Blair starts Coach (NYSE: COH) with an Outperform.
Credit Agricole initiates Altria (NYSE: MO) with an Outperform, and $32 price target.
Jefferies assumes Acme Packet (Nasdaq: APKT) at Buy rating and $35 price target. Click Here for more color.
Maxim Group begins Human Genome Sciences (Nasdaq: HGSI) with a Buy, and price target of $14.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Bernstein upgrades Boston Scientific (NYSE: BSX) from Market Perform to Outperform, its price target raised $6.50 to $7.
Deutsche Bank lifts Health Management (NYSE: HMA) from Hold to Buy, its price target lowered from $9.50 to $8.50. Click Here for more color.
Morgan Stanley raises UBS AG (NYSE: UBS) from Equal Weight to Overweight.
Canaccord Genuity boosts Garmin Ltd. (Nasdaq: GRMN) from Hold to Buy, its price target raised from $37 to $47.50. Click Here for more color.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES
BofA/Merrill Lynch downgrades Covanta (NYSE: CVA) from Buy to Neutral.
Bernstein lowers Stryker (NYSE: SYK) from Outperform to Market Perform, its price target cut from $57 to $56.
UBS reduces D.R. Horton (NYSE: DHI) from Buy to Neutral. Click Here for more color.
Goldman Sachs drops Walgreen (NYSE: WAG) from Buy to Neutral with a price target of $35 (down from $38). Click Here for more color.
For daily real-time Downgrades go to http://www.streetinsider.com/downgrades
NEW COVERAGE
William Blair starts Coach (NYSE: COH) with an Outperform.
Credit Agricole initiates Altria (NYSE: MO) with an Outperform, and $32 price target.
Jefferies assumes Acme Packet (Nasdaq: APKT) at Buy rating and $35 price target. Click Here for more color.
Maxim Group begins Human Genome Sciences (Nasdaq: HGSI) with a Buy, and price target of $14.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- UPDATE: Auriga Starts Teva Pharma (TEVA) at Hold; Sidelined Until New CEO Is Convincing
- UPDATE: Global Hunter Securities Starts Kosmos Energy (KOS) at Buy; High Risk, High Reward
- UPDATE: Ralph Lauren Corp (RL) Reports Solid Q4 Results; Guides FY13 Sales
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Deutsche Bank, UBS, William Blair, Morgan Stanley, Jefferies & Co, Merrill Lynch, Bank of America, Genuity Capital Markets, Maxim Group, Notable Analyst Rating Changes, Credit Agricole, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
